Cellular phase separation may play a previously underappreciated role in regulating kinase activity, offering therapeutic ...

Researchers suggest study is the first to translate cell-free biomanufacturing from laboratory to real-world use, across multiple geographic settings.

Crystalys Therapeutics has dosed the first patient with its once daily oral, URAT1 inhibitor dotinurad in its Phase II AMETHYST trial (NCT07535034), designed to assess dotinurad’s effectiveness in ...

Neuropixels Opto is a single probe combining electrophysiology and optogenetics that simultaneously records and controls ...

A new method screens large libraries of synthetic cyclic peptides to identify compounds that can enter cells for therapeutic effect.

In a quest to provide more relevant translational data, traditional in vivo models join forces with new approach methodologies.

A strong quarterly earnings report that beat analyst expectations, growth that extended into core pharma and biotech tools, plus improved investor guidance on revenue, operating margin, and earnings ...

Some of the forces that shape biopharma cluster development are constants year after year, such as the emergence of startups from university and research institute labs to develop new treatments, ...

Today, the transition to recombinants is underway, as they are being approved and adopted in IVD assays around the globe. I witnessed firsthand the shortage of native starting materials and helped ...

The 2030 patent cliff may either decimate revenue streams or provide an opportunity for innovation that can transform the biopharmaceutical industry. As it stands today, some 200 biopharmaceuticals ...

Ahead of ASCO 2026, Illumina unveiled an early-access MRD research kit using whole-genome sequencing and DRAGEN analysis.

Neuronal protein tracing maps how waste exits the brain, revealing region‑specific drainage routes and showing how inflammation and Alzheimer’s disrupt clearance.